Your browser doesn't support javascript.
loading
Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons Living with Psoriatic Disease.
Gustafson, A C; Gelfand, J M; Davies, J; Lieberman, A E; Mason, J B; Armstrong, A W; Ogdie, A; Mehta, N N; Barbieri, J S; Beidas, R S.
Afiliação
  • Gustafson AC; University of Pennsylvania, Philadelphia, PA, United States.
  • Gelfand JM; Department of Dermatology, Perelman Center for Advanced Medicine, Philadelphia, PA, United States.
  • Davies J; College of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, United States.
  • Lieberman AE; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Mason JB; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Armstrong AW; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
  • Ogdie A; Department of Rheumatology, Perelman Center for Advanced Medicine, Philadelphia, PA, United States.
  • Mehta NN; FAHA Section of Inflammation and Cardiometabolic Diseases, National Institute of Health, Bethesda, MD, United States.
  • Barbieri JS; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, United States.
  • Beidas RS; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
J Psoriasis Psoriatic Arthritis ; 7(4): 174-186, 2022 Oct.
Article em En | MEDLINE | ID: mdl-38148879
ABSTRACT

Background:

Psoriasis is an immune-mediated disease associated with excess risk for cardiovascular disease (CVD). Guidelines recognize psoriasis as a CVD risk enhancer; however, psoriasis patients often do not have CVD risk factors identified nor managed.

Objective:

This study examines strategies to improve CVD prevention care from the perspective of dermatologists and patients with psoriasis.

Methods:

Qualitative interviews were conducted using the Consolidated Framework for Implementation Research to examine the perspectives of physicians (N = 16) and patients with psoriatic disease (N = 16) on barriers/facilitators to CVD prevention. Interviews were transcribed and coded using an integrated approach designed to enhance reliability and validity using NVivo software.

Results:

We found three major themes suggesting areas to target for the future (1) Appropriateness perceptions of whether CVD care should be deployed in this setting by both clinicians and patients, (2) Feasibility whether CVD prevention care could be integrated into the current structure of specialist practice, and (3) Care Coordination an interest by all parties to better integrate a team approach in CVD preventative care to reduce duplicative efforts, work practically in an already existing system rather than reinventing the wheel, and progress with the patients' best interests in mind.

Conclusions:

These findings will inform the design of a clinical trial comparing the effectiveness of specialist clinician implementation of CVD guideline-based prevention care in patients with psoriasis. Ultimately, this study aims to increase the lifespan and health of patients living with psoriatic disease by decreasing barriers to their receiving appropriate CVD prevention care.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Idioma: En Revista: J Psoriasis Psoriatic Arthritis Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Idioma: En Revista: J Psoriasis Psoriatic Arthritis Ano de publicação: 2022 Tipo de documento: Article